ENTITY
Shanghai MicroPort MedBot

Shanghai MicroPort MedBot (2252 HK)

90
Analysis
Health Care • China
Shanghai MicroPort MedBot is a surgical robot company that designs, develops, manufactures, and commercializes surgical robots and associated digital surgical solutions. Its product portfolio covers surgical specialties including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture, with key products like the Toumai laparoscopic surgical robot, DFVision 3D electronic laparoscope, and SkyWalker orthopedic surgical robot. The company is headquartered in Shanghai, China, and was officially established in 2015.
more
•01 Nov 2021 16:51

Microport MedBot IPO:  Thoughts on First Day Trading

Microport MedBot priced its IPO at HK$43.20 per share and we believe there is very limited upside to the company's shares as our SOTP valuation...

Share
•01 Nov 2021 11:22

MicroPort MedBot IPO Trading - Decent Demand But Upside Is Limited from the Top-End

Shanghai MicroPort MedBot Group (MM), a surgical robot company, raised around US$200m in its Hong Kong IPO. In this note we will talk about the...

Logo
401 Views
Share
•24 Oct 2021 08:41

ECM Weekly (24th October 2021) - Japan Post, SiteMinder, MicroPort Medbot, PolicyBazaar

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
532 Views
Share
•22 Oct 2021 20:11

MicroPort MedBot IPO: Forecasts, Peer Comparison and Valuation

Our SOTP valuation (using peer comps and past deal multiples) suggests that MicroPort's IPO is attractive only at the lower end of the indicative...

Share
•21 Oct 2021 16:05

MicroPort MedBot IPO: Valuation Insights

Our valuation analysis suggests that the IPO price range is full and we would remain on the sidelines awaiting a better entry opportunity.

Logo
562 Views
Share
x